REMINDER: Please join Schultze Special Purpose Acquisition Corp. (SAMA) and the executive management team from Clever Leaves International Inc., for an update on the proposed merger, with Clever Leaves Advisory Board Member and former U.S. Senate Majority Leader, Tom Daschle, available to discuss the changing landscape for cannabis legalization in the US and globally. Management and Senator Daschle will walk through a brief investor presentation update and take questions from the audience.
Live Management Presentation and Q&A
Please join
Schultze Special Purpose Acquisition Corp. (SAMA)
&
Clever Leaves Executive Management
for an online investor presentation and live Q&A discussion regarding their proposed merger
Date: Monday, November 16th
Time: 1:00 p.m. (Eastern Time)
Andres Fajardo – President, Clever Leaves
George Schultze – Chairman and CEO, SAMA
Gary Julien – EVP and Director, SAMA
Gavin O’Reilly – Managing Director, Cowen and Company
* Management will be taking questions from the audience *
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...